demonstrated that CRC released integrin beta-like 1 (ITGBL1)-rich EVs to activate resident fibroblasts in lung and liver tissue through the ITGBL1-TNFAIP3-NF-κB signaling pathway. The gene discussed is NFKB1; the disease is colorectal carcinoma.